Long term experience of gamma knife radiosurgery for benign skull base meningiomas.
TL;DR: GKRS has proved to be an effective alternative to microsurgical resection, radiotherapy, and Linac based radiosurgery for adjunctive and primary treatment of selected patients with basal meningiomas and should be used more frequently in the therapeutic management of benign skull base mening iomas.
read more
Abstract: Objectives: As most reports on the gamma knife have related only to short or mid-term results, we decided to evaluate the effectiveness and toxicity of radiosurgical treatment for benign skull base meningiomas in 200 patients with a follow up of 5–12 years to define the role of gamma knife radiosurgery (GKRS) for basal meningiomas and to provide further data for comparison with other treatment options.
Methods: In total, 99 patients were treated with a combination of microsurgical resection and GKRS. In 101 patients, GKRS was performed as the sole treatment option. Tumour volumes ranged from 0.38 to 89.8 cm3 (median 6.5 cm3), and doses of 7–25 Gy (median 12 Gy) were given to the tumour borders at covering isodose volume curves (range 20–80%, median 45%).
Results: The actuarial progression free survival rate was 98.5% at 5 years and 97.2% at 10 years. Passing radiation induced oedema occurred in two patients (1%). The neurological status improved in 83 cases (41.5%), remained unaltered in 108 (54%), and deteriorated in 9 (4.5%). Worsening was transient in seven patients (3.5%) and unrelated to tumour or treatment in one (0.5%). Repeated microsurgical resection was performed in five patients following GKRS (2.5%).
Conclusions: GKRS has proved to be an effective alternative to microsurgical resection, radiotherapy, and Linac based radiosurgery for adjunctive and primary treatment of selected patients with basal meningiomas. Because of the excellent long term tumour control rate and low morbidity associated with GKRS, this treatment option should be used more frequently in the therapeutic management of benign skull base meningiomas.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review
Leland Rogers,Igor J. Barani,Marc C. Chamberlain,Thomas Kaley,Michael W. McDermott,Jeffrey Raizer,David Schiff,Damien C. Weber,Patrick Y. Wen,Michael A. Vogelbaum +9 more
TL;DR: This review summarizes the published literature regarding the treatment of newly diagnosed and recurrent meningioma with an emphasis on outcomes stratified by WHO tumor grade, and focuses on patient outcomes following treatment with surgery or radiation therapy.
Radiosurgery as definitive management of intracranial meningiomas.
Douglas Kondziolka,David Mathieu,L. Dade Lunsford,Juan J. Martin,Ricky Madhok,Ajay Niranjan,John C. Flickinger +6 more
TL;DR: This study confirms the role of radiosurgery as an effective management choice for patients with small to medium-sized symptomatic, newly diagnosed or recurrent meningiomas of the brain.
437
Evolution of surgical approaches in the treatment of petroclival meningiomas: a retrospective review.
Nicholas C. Bambakidis,U Kumar Kakarla,Louis J. Kim,Peter Nakaji,Randall W. Porter,C. Phillip Daspit,Robert F. Spetzler +6 more
TL;DR: In this article, the surgical approaches used at a single institution to treat petroclival meningioma and evaluated changes in method utilization over time were examined retrospectively, and the progression-free survival rate for patients treated without petrosal approaches was 96%.
167
Long-term control of petroclival meningiomas through radiosurgery Clinical article
Thomas Flannery,Hideyuki Kano,L. Dade Lunsford,Sait Sirin,Matthew J. Tormenti,Ajay Niranjan,John C. Flickinger,Douglas Kondziolka +7 more
TL;DR: In this 21-year experience, GKS for petroclival meningiomas obviated initial or further resection in 98% of patients and was associated with a low risk of adverse radiation effects.
155
Advances in multidisciplinary therapy for meningiomas
Priscilla K. Brastianos,Evanthia Galanis,Nicholas Butowski,Jason Chan,Ian F. Dunn,Roland Goldbrunner,Christel Herold-Mende,Franziska M. Ippen,Christian Mawrin,Michael W. McDermott,Andrew E. Sloan,James Snyder,Ghazaleh Tabatabai,Marcos Tatagiba,Joerg C. Tonn,Patrick Y. Wen,Kenneth Aldape,Farshad Nassiri,Gelareh Zadeh,Michael D. Jenkinson,David R. Raleigh +20 more
TL;DR: Two of the first cooperative group studies evaluating the outcomes of adjuvant radiation therapy in higher-risk meningiomas have shown promising preliminary results, and several clinical trials are under way evaluating the efficacy of chemotherapies, such as trabectedin, and novel molecular agents targeting Smoothened, AKT1, and focal adhesion kinase in patients with recurrent mening iomas.
137
References
Nonparametric Estimation from Incomplete Observations
Edward L. Kaplan,Paul Meier +1 more
TL;DR: In this article, the product-limit (PL) estimator was proposed to estimate the proportion of items in the population whose lifetimes would exceed t (in the absence of such losses), without making any assumption about the form of the function P(t).
The new WHO classification of brain tumours.
TL;DR: The new edition of the World Health Organization (WHO) book on ‘Histological Typing of Tumours of the Central Nervous System’ reflects the progress in brain tumour classification which has been achieved since publication of the first edition in 1979.
1.6K
Meningioma: analysis of recurrence and progression following neurosurgical resection
TL;DR: The rates of survival, tumor recurrence, and tumor progression were analyzed in 225 patients with meningioma who underwent surgery as the only treatment modality between 1962 and 1980, and there was no difference in the recurrence/progression rates according to the patients' age or sex, or the duration of symptoms.
1K
A simple scoring ratio to index the conformity of radiosurgical treatment plans
Ian Paddick
- 13 May 2009
TL;DR: A new conformity index is derived that gives an objective score of conformity for a treatment plan and gives no false scores.
973
A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note
TL;DR: A new conformity index is derived that gives an objective score of conformity for a treatment plan and gives no false scores.
916